SCHEMBL6237111

SCHEMBL6237111

COc1ccc([N+](=O)[O-])c(C)c1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.50
ALDH1A1 P00352 5/20 0.50
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
MAPT P10636 6/20 0.44
LMNA P02545 4/20 0.44
MAPK1 P28482 2/20 0.44
KDM4E B2RXH2 4/20 0.44
POLB P06746 1/20 0.44
CTDSP1 Q9GZU7 1/20 0.44
GAA P10253 1/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
TTR P02766 1/20 0.42
ALB P02768 1/20 0.42
THRB P10828 1/20 0.42
G6PD P11413 1/20 0.41
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7351987 0.86 TDP1 (0.50) TDP1ALDH1A1HTTL3MBTL1MAPT
SCHEMBL9820288 0.85 TDP1 (0.53) TDP1ALDH1A1HTTL3MBTL1MAPT
SCHEMBL31047331 0.85 TDP1 (0.53) TDP1ALDH1A1HTTL3MBTL1MAPT
SCHEMBL31077739 0.83 ALDH1A1 (0.55) TDP1ALDH1A1L3MBTL1MAPTLMNA
SCHEMBL4466194 0.83 ALDH1A1 (0.55) TDP1ALDH1A1L3MBTL1MAPTLMNA
SCHEMBL8205960 0.81 TDP1 (0.53) TDP1ALDH1A1L3MBTL1MAPTLMNA
SCHEMBL11983744 0.80 ALDH1A1 (0.52) TDP1ALDH1A1L3MBTL1MAPTLMNA
SCHEMBL4871070 0.79 PRSS1 (0.43) TDP1ALDH1A1MAPTLMNAMAPK1
SCHEMBL8537615 0.79 TDP1 (0.44) TDP1ALDH1A1HTTL3MBTL1MAPT
SCHEMBL32670661 0.79 TDP1 (0.50) TDP1ALDH1A1HTTL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0993441-B1 INHIBITORS OF p38 VERTEX PHARMA (US) 2005-06-01 EP disclosed
US-6093742-A TREATMENT OF INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, DESTRUCTIVE BONE DISORDERS, PROLIFERATIVE DISORDERS, INFECTIOUS DISEASES, VIRAL DISEASE, AND NEURODEGENERATIVE DISEASES VERTEX PHARMACEUTICALS, INC. (US) 2000-07-25 US disclosed
EP-0993441-A1 INHIBITORS OF p38 Vertex Pharmaceuticals Incorporated (US) 2000-04-19 EP disclosed
WO-1999000357-A1 INHIBITORS OF p38 VERTEX PHARMACEUTICALS INCORPORATED (US) 1999-01-07 WO disclosed